Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Acquati

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|September 30, 2006
Targeted therapies in melanomaPaola Queirolo, Mirko Acquati
Melanoma Research|September 24, 2005
Biochemotherapy in metastatic melanoma: quo vadis?Paola Queirolo, Mirko Acquati
Tumori|August 8, 2007
Medical treatment of uveal melanomaPaola Queirolo, Mirko Acquati
Melanoma Research|September 24, 2005
Update: current management issues in malignant melanomaPaola Queirolo, Mirko Acquati, John M Kirkwood, et al.
Anticancer Research|August 19, 2007
Primary melanoma of the esophagus with non-metastatic dark lymph nodes in a female breast cancer patientNicola Solari, Mirko Acquati, Paola Queirolo, et al.
Melanoma Research|October 15, 2013
The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survivalStefania Vecchio, Francesco Spagnolo, Domenico F Merlo, et al.
Anticancer Research|May 4, 2005
Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancerSilvana Chiara, Maria Teresa Nobile, Laura Tomasello, et al.
Journal of Bone Oncology|January 11, 2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDEDaniele Santini, Saverio Cinieri, Donatello Gasparro, et al.
Journal of the National Cancer Institute|April 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort studyLuca Cantini, Francesco Paoloni, Federica Pecci, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|September 30, 2006
Targeted therapies in melanomaPaola Queirolo, Mirko Acquati
Melanoma Research|September 24, 2005
Biochemotherapy in metastatic melanoma: quo vadis?Paola Queirolo, Mirko Acquati
Tumori|August 8, 2007
Medical treatment of uveal melanomaPaola Queirolo, Mirko Acquati
Melanoma Research|September 24, 2005
Update: current management issues in malignant melanomaPaola Queirolo, Mirko Acquati, John M Kirkwood, et al.
Anticancer Research|August 19, 2007
Primary melanoma of the esophagus with non-metastatic dark lymph nodes in a female breast cancer patientNicola Solari, Mirko Acquati, Paola Queirolo, et al.
Melanoma Research|October 15, 2013
The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survivalStefania Vecchio, Francesco Spagnolo, Domenico F Merlo, et al.
Anticancer Research|May 4, 2005
Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancerSilvana Chiara, Maria Teresa Nobile, Laura Tomasello, et al.
Journal of Bone Oncology|January 11, 2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDEDaniele Santini, Saverio Cinieri, Donatello Gasparro, et al.
Journal of the National Cancer Institute|April 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort studyLuca Cantini, Francesco Paoloni, Federica Pecci, et al.
Pageof 1